Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: the Lira-1 study.
about
Dulaglutide (LY-2189265) for the treatment of type 2 diabetes.Effects of liraglutide on cardiovascular risk factors in patients with type 1 diabetes.GLP-1 receptor agonists in type 1 diabetes: a proof-of-concept approach.The effects of metformin in type 1 diabetes mellitus.Pharmacological Treatment in Diabetes Mellitus Type 1 - Insulin and What Else?
P2860
Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: the Lira-1 study.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Efficacy and safety of the glu ...... olled study: the Lira-1 study.
@ast
Efficacy and safety of the glu ...... olled study: the Lira-1 study.
@en
type
label
Efficacy and safety of the glu ...... olled study: the Lira-1 study.
@ast
Efficacy and safety of the glu ...... olled study: the Lira-1 study.
@en
prefLabel
Efficacy and safety of the glu ...... olled study: the Lira-1 study.
@ast
Efficacy and safety of the glu ...... olled study: the Lira-1 study.
@en
P2093
P2860
P50
P1433
P1476
Efficacy and safety of the glu ...... olled study: the Lira-1 study.
@en
P2093
Christian Seerup Frandsen
Tanja Stenbæk Hansen
Thomas Almdal
P2860
P304
P356
10.1136/BMJOPEN-2015-007791
P577
2015-04-02T00:00:00Z